NeuroMetrix, Inc. Announces Date for Third Quarter 2022 Financial Results Conference Call
October 12 2022 - 3:47PM
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to
issue its 2022 third quarter financial results before the opening
of the market on Oct 20, 2022. The Company will host a conference
call at 8:00 a.m., Eastern Time on Oct 20, 2022 to discuss its
financial results as well as business developments affecting the
Company.
For participants who wish to access the Earnings Call live via
telephone and be able to ask questions, please register in advance
here. Upon registering, a dial-in and unique PIN will be provided
on screen and via email to join the call. An audio-only webcast of
the call, along with the earnings press release and accompanying
condensed financial statements, may be accessed in the Investors
section of the Company’s website at www.NeuroMetrix.com. Following
the conference call, a replay of the call will be available for one
year on the Company's Investors section of the website.
About NeuroMetrix
NeuroMetrix is an innovation-driven company with a mission to
improve individual and population health through innovative medical
devices and technology solutions for neurological disorders and
pain syndromes. The Company has three commercial products.
DPNCheck® is a diagnostic device that provides rapid, point-of-care
detection of peripheral neuropathies. ADVANCE® is a diagnostic
device that provides automated, in-office nerve conduction studies
for the evaluation of focal neuropathies. Quell® Fibromyalgia
is a wearable neuromodulator that is the first and only
FDA-authorized medical device to help reduce the symptoms of
fibromyalgia. For more information, visit www.NeuroMetrix.com.
NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief
Financial Officerneurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Mar 2024 to Apr 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Apr 2023 to Apr 2024